Humoral anti-SARS-CoV-2 immune response for different strains after Sinovac-CoronaVac and Oxford/AstraZeneca (ChAdOx1-S) full vaccination on a healthcare population in Brazil

• Main Authors: Maicon Jeferson Silva de Oliveira (Author), Beatriz Birelli do Nascimento (Author), Fernanda de Assis Oliveira (Author), Mahelly Bueno de Almeida (Author), Márcio Rodrigues (Author), Flavia Cristina Cardoso Carvalho (Author), Éric Diego Barioni (Author), Rodrigo Azevedo Loiola (Author), Rômulo Tadeu Dias de Oliveira (Author), Gustavo Henrique Oliveira da Rocha (Author)
• Format: Book
• Published: Editora Uningá, 2024-03-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

COVID-19, caused by the SARS-CoV-2 virus, is a global respiratory syndrome with high mortality rates. Vaccination is currently the only proven method to prevent the disease, although the role of lab data in assessing efficacy remains uncertain. This study aimed to assess spike-binding and neutralizi...